Kerrisdale Capital Tells Benzinga "We Are Still Short Altimmune (ALT)"
Portfolio Pulse from Benzinga Newsdesk
Kerrisdale Capital has confirmed to Benzinga that they continue to hold a short position on Altimmune (ALT), indicating a bearish outlook on the company's stock.
February 26, 2024 | 1:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Kerrisdale Capital's continued short position on Altimmune (ALT) suggests a negative outlook on the company's stock performance in the short term.
Kerrisdale Capital's decision to remain short on Altimmune (ALT) is a strong bearish signal, likely influencing investor sentiment and potentially leading to a decrease in ALT's stock price in the short term. Their position as a notable investment firm adds weight to this outlook, making it a significant factor for investors to consider.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100